awards grant
- "DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"
- "Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment - SUPPLEMENT COST EXTENSION
- 5th Annual International Symposium: Improving Breast Cancer Management and Outcomes
- A Digital Twin for rectal cancer to guide adaptive radiotherapy
- A systems-level approach to therapeutically target STING in cancer
- An engineered bacterial reporter gene fusion for radiotheranostics
- An urinary drug disposing approach for treatment of bladder Cancer
- Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection
- B cell determinants of EBV latency
- Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)
- CAP-IT Center for LNP RNA Immunoprevention
- CAR T Cells for Advanced Thyroid Cancer
- CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention
- Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
- Cancer Pharmacology
- Characterizing stem cell-like B cell subpopulations and dissecting their role in tumorigenesis
- Characterizing the autologous fat graft microenvironment resulting from differential intraoperative processing techniques: A comparative analysis and its clinical implications
- Cholesterol Metabolism in Mesenchymal Colorectal Cancer
- Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
- Computational and experimental methods for scalable identification of oncogenic non-coding regions
- Copper-Mediated Metabolic Reprogramming And ECM Alterations In TNBC Metastasis
- Culturally Competent Communication Intervention to Improve Latinos'' Engagement in Advance Care Planning
- Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumors
- DOTA-based pre-targeting of alpha emitters
- Defining Epidrivers of CLL Evolution in Response to Targeted Therapy
- Defining host-microbiota interactions during colorectal cancer and immune checkpoint blockade
- Defining novel mechanisms of microbiota in regulating anti-tumor responses
- Defining the oncogenic potential and therapeutic dependencies of PDAC-associated KRAS variants
- Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies
- Diffusion MRI of Treatment Response for De-escalation of Radiation Therapy
- Discovery of a stem cell driving breast cancer spine metastases
- Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystem
- Dissecting the in vivo stromal metabolic and inflammatory crosstalk in colorectal cancer
- Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis
- Dynamics of Immune Response in Irradiated Rectal Cancer
- ER stress-driven IRE1a-XBP1 signaling in lung cancer
- ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate Cancer
- Effectiveness and implementation of a decision support tool to improve surgical decision making in young women with breast cancer
- Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche
- Evaluation of Transperineal Biopsy under Local Anesthesia, a Novel approach to Decrease Post-Biopsy Infections and Improve Cancer Detection
- Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes
- Exploiting tumor metabolism to optimize T cell therapy
- Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy
- Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancer
- Identifying molecular vulnerabilities of ALT-dependent cancers
- Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
- Imaging-Guided Fine tuning of CAR T Cell Affinity to Limit T Cell Cytotoxicity to Tumor Antigen
- Immunometabolic Programs Controlled by ER Stress in Cancer
- Immunoregulatory role of lung-resident club cell factors in lung cancer
- Innate lymphoid cell regulation of the host-microbiota interactions in cancer
- Innate-like lymphocyte regulation of host-microbiota interactions in cancer
- Intercepting progression from pre-invasive to invasive lung adenocarcinoma
- Intercepting progression from pre-invasive to invasive lung adenocarcinoma
- Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer
- Mechanism-Based Targeting of Mantle Cell Lymphoma
- Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
- Molecular mechanisms driving mesenchymal colorectal cancer
- Molecular mechanisms driving therapy-induced lineage plasticity
- Next-Gen Oncopathology Program
- Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate Cancer
- Novel proteasome inhibitors targeting both beta5 and beta2 subunits for treatment of triple negative breast cancer
- Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing
- Optimization of strategies to improve NCI-sponsored clinical trial participation throughout the Weill Cornell Medicine - Meyer Cancer Center Sphere
- Optimizing the Delivery of Diabetes Management During Breast Cancer Care
- PSMA/MR-guided Stereotactic Body Radiotherapy for High Risk Prostate Cancer
- Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
- Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
- Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)
- Phosphoinositides and Cancer Metabolism
- Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
- Precision use of radiation for in situ cancer immunization
- Preventing follicular lymphoma progression and transformation through precision therapy
- Probing cytosolic nucleic acid sensing pathways in cancer
- Psychosocial Approaches to Better Understanding & End-Stage Cancer Care (PROTECT)
- Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis
- Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies
- Role of FAP-positive cells in immune response to irradiated glioblastoma
- Role of chromatin remodeling complex BAF in immunity and lymphoma
- Role of novel onco-histone mutations in B-cell malignancies
- Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
- Role of the smooth muscle layer in bladder cancer biology and progression: a systems and experimental approach
- Role of the stromal microenvironment in B-cell lymphoma progression and immune escape
- Role of the stromal microenvironment in B-cell lymphoma progression and immune escape
- SAMBAI: Societal, Ancestry and Molecular Biology Analyses of Inequalities
- Single-cell dissection of cellular programs driving diffuse glioma evolution
- Small LIVER Cancer: Development of a Multi-Level Intervention to Improve Access to CURE (LIVER:CURE)
- Somatostatin Receptor 2 Expression in Pituitary Neuroendocrine Tumors as a Basis for PET/MRI guided Subtype Stratification and Radiotherapy Planning
- Structural Racism and Cardiovascular Outcomes Among Cancer Survivors
- Systemic regulation of metastasis
- Targeting APOBEC3A-induced genetic heterogeneity and drug resistance in bladder cancer
- Targeting Epigenetic Circuits in B-Cell Lymphomas
- Targeting Latency Switch in EBV+ Lymphomas
- Targeting MALT1 to Enhance Anti-Lymphoma Immunity and Response to Immunotherapy
- Targeting drivers of tumor heterogeneity to block the progression to neuroendocrine prostate cancer
- Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
- The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
- The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles
- The role of the mycobiome in cancer
- Therapeutic Targeting of SIRT3 for Aggressive and Refractory Lymphomas
- To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models
- Tumor selective inhibition of the WNT pathway
- UBR5''s Mechanisms of Action in Tumorigenesis and Immunoregulation
- Ultra-High Performance Brain-dedicated PET scanner for Neurology and Neuro-oncology imaging
- Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer